ATE489101T1 - Wiederherstellung der gelenken mit mesenchymalen stammzellen - Google Patents

Wiederherstellung der gelenken mit mesenchymalen stammzellen

Info

Publication number
ATE489101T1
ATE489101T1 AT01930730T AT01930730T ATE489101T1 AT E489101 T1 ATE489101 T1 AT E489101T1 AT 01930730 T AT01930730 T AT 01930730T AT 01930730 T AT01930730 T AT 01930730T AT E489101 T1 ATE489101 T1 AT E489101T1
Authority
AT
Austria
Prior art keywords
stem cells
mesenchymal stem
joint
joint restoration
restoration
Prior art date
Application number
AT01930730T
Other languages
German (de)
English (en)
Inventor
Francis Barry
J Murphy
Robert Deans
David Fink
Annemarie Moseley
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26894885&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE489101(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Application granted granted Critical
Publication of ATE489101T1 publication Critical patent/ATE489101T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30756—Cartilage endoprostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/38—Joints for elbows or knees
    • A61F2/3872—Meniscus for implantation between the natural bone surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
AT01930730T 2000-04-25 2001-04-24 Wiederherstellung der gelenken mit mesenchymalen stammzellen ATE489101T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19954900P 2000-04-25 2000-04-25
US23610600P 2000-09-28 2000-09-28
PCT/US2001/013267 WO2001080865A2 (en) 2000-04-25 2001-04-24 Joint repair using mesenchymal stem cells

Publications (1)

Publication Number Publication Date
ATE489101T1 true ATE489101T1 (de) 2010-12-15

Family

ID=26894885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01930730T ATE489101T1 (de) 2000-04-25 2001-04-24 Wiederherstellung der gelenken mit mesenchymalen stammzellen

Country Status (10)

Country Link
US (5) US20020005205A1 (enExample)
EP (1) EP1276486B2 (enExample)
JP (4) JP5090604B2 (enExample)
AT (1) ATE489101T1 (enExample)
AU (2) AU2001257236B2 (enExample)
CA (1) CA2405345C (enExample)
DE (1) DE60143517D1 (enExample)
ES (1) ES2353061T5 (enExample)
PT (1) PT1276486E (enExample)
WO (1) WO2001080865A2 (enExample)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001080865A2 (en) * 2000-04-25 2001-11-01 Osiris Therapeutics, Inc. Joint repair using mesenchymal stem cells
DE10139783C1 (de) * 2001-08-14 2003-04-17 Transtissue Technologies Gmbh Zellzusammensetzungen zur Behandlung von Osteoarthrose, sowie Verfahren zu deren Herstellung
JP2005511083A (ja) 2001-12-07 2005-04-28 ジェロン コーポレイション ヒト胚幹細胞由来の軟骨細胞前駆細胞
AR047712A1 (es) * 2002-09-07 2006-02-15 Royal Veterinary College Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
US8012693B2 (en) * 2003-12-16 2011-09-06 3M Innovative Properties Company Analysis of chemically crosslinked cellular samples
ES2385450T3 (es) * 2004-03-22 2012-07-25 Osiris Therapeutics, Inc. Células madre mesenquimatosas y sus utilizaciones
AU2015252160A1 (en) * 2004-03-22 2015-11-26 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
AU2012205269B2 (en) * 2004-03-22 2015-08-27 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
CA2564679C (en) 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
US20110177492A1 (en) * 2005-06-16 2011-07-21 3M Innovative Properties Company Method of classifying chemically crosslinked cellular samples using mass spectra
WO2007025166A2 (en) 2005-08-25 2007-03-01 Repair Technologies, Inc. Devices, compositions and methods for the protection and repair of cells and tissues
GB0600972D0 (en) * 2006-01-18 2006-03-01 Univ Leeds Enrichment of cells
GEP20135796B (en) 2006-03-07 2013-04-10 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
US20080260703A1 (en) * 2007-04-23 2008-10-23 Medistem Labortories Treatment of Insulin Resistance and Diabetes
US9095562B2 (en) 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
AU2013203054B2 (en) * 2007-08-06 2017-05-18 Mesoblast, Inc. Methods of generating, repairing and/or maintaining connective tissue in vivo
CN103169731A (zh) * 2007-08-06 2013-06-26 成血管细胞系统公司 用于体内生成、修复和/或维护结缔组织的方法
ES2704153T3 (es) * 2007-08-06 2019-03-14 Mesoblast Inc Células STRO-1brillantes para su uso en el tratamiento de enfermedades de tejidos conectivos
WO2009085969A2 (en) 2007-12-19 2009-07-09 Regenerative Sciences, Llc Compositions and methods to promote implantation and engrafment of stem cells
US20100285134A1 (en) 2008-02-15 2010-11-11 Bone Therepeutics Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
EP2090308A1 (en) * 2008-02-15 2009-08-19 Bone Therapeutics Pharmaceutical composition for the treatment or prevention of osteoarticular diseases
BRPI0905715A2 (pt) * 2008-02-15 2015-07-14 Bone Therapeutics Composição farmacêutica e kit de componentes
CN102026546A (zh) 2008-03-14 2011-04-20 再生科学有限责任公司 软骨修复的合成物和方法
KR20170104643A (ko) 2008-06-25 2017-09-15 메소블라스트, 아이엔씨. 추간판의 치료 및/또는 재구성
WO2010056336A1 (en) * 2008-11-14 2010-05-20 Howmedica Osteonics Corp. Cells for joint fluid
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
AR074551A1 (es) 2008-12-05 2011-01-26 Regenerative Sciences Llc Metodos y composiciones para facilitar la reparacion de tejido avascular
WO2010099463A2 (en) 2009-02-27 2010-09-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Joint bioscaffolds
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
CA2777783A1 (en) * 2009-10-13 2011-04-21 Allocure Inc. Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
CA2809272A1 (en) * 2010-08-31 2012-03-08 Cook General Biotechnology Llc Systemic, allogenic stem cell therapies for treatment of diseases in animals
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
US8709401B2 (en) 2011-02-25 2014-04-29 Howmedica Osteonics Corp. Primed stem cells and uses thereof to treat inflammatory conditions in joints
EP2726603B1 (en) 2011-06-29 2020-04-01 Biorestorative Therapies, Inc. Brown fat cell compositions and methods
GB201202319D0 (en) 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
US9457051B2 (en) * 2013-01-22 2016-10-04 Animal Cell Therapies, Inc. Use of stem cells or progenitor cells to treat, delay, prevent, or repair tearing of cruciate ligaments
RU2678878C2 (ru) 2013-02-12 2019-02-05 Репликэл Лайф Сайенсиз Инк. Композиции и способы для лечения и восстановления сухожилий
US9186253B2 (en) 2013-02-22 2015-11-17 Allosource Cartilage mosaic compositions and methods
WO2014150784A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
WO2014151939A1 (en) 2013-03-15 2014-09-25 Allosource Perforated osteochondral allograft compositions
US20150010606A1 (en) * 2013-07-08 2015-01-08 Arthrex, Inc. Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase
US9597099B2 (en) * 2013-07-29 2017-03-21 Covidien Lp Energy-based treatment methods for refractory gout
WO2015016357A1 (ja) 2013-08-01 2015-02-05 株式会社ツーセル 軟骨損傷治療剤及びその製造方法
AU2015211075A1 (en) 2014-01-28 2016-09-08 Medivation Technologies, Inc. Targeted therapeutics
WO2015121380A1 (en) 2014-02-12 2015-08-20 National University Of Ireland, Galway Selection and use of stem cells
TW201538730A (zh) * 2014-02-12 2015-10-16 Replicel Life Sciences Inc 用於治療骨骼、關節及軟骨之組合物及方法
RU2559089C1 (ru) * 2014-04-22 2015-08-10 Государственное автономное учреждение здравоохранения "Республиканская клиническая больница Министерства здравоохранения Республики Татарстан" Способ восстановления дефектов гиалинового хряща суставных поверхностей суставов конечностей
EP3209768A1 (en) 2014-07-25 2017-08-30 Recellerate Inc. Methods of treating exercise-induced pulmonary hemorrhage
TWI566774B (zh) * 2014-10-06 2017-01-21 佛教慈濟醫療財團法人花蓮慈濟醫院 治療關節疾病的組成物及其方法
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
WO2017019832A1 (en) 2015-07-29 2017-02-02 Medivation Technologies, Inc. Methods and compositions using repair cells and cationic dyes
KR101720329B1 (ko) 2015-12-11 2017-03-28 주식회사 에이티앤씨 무선통신 단말기용 nfc 및 mst 공용 안테나 장치
AU2017241626B2 (en) 2016-03-28 2022-03-31 Gallant Pet, Inc. Viable cell compositions, and methods related to same
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
CN106075585B (zh) * 2016-07-08 2019-06-21 福建师范大学 一种基于人工肌腱支架材料的组织工程化人工肌腱移植物的制备方法
JP7516045B2 (ja) * 2016-10-07 2024-07-16 サイトリ・セラピューティクス株式会社 筋骨格疾患のための再生・細胞療法
US9980984B2 (en) 2016-10-13 2018-05-29 Kenneth Allen Pettine Treatment of inflammation of osteoarthritic knees with mesenchymal stem cells
EP3543331A4 (en) 2016-11-15 2020-07-01 Kaneka Corporation CELL POPULATION CONTAINING MESENCHYMAL STEM CELLS DERIVED FROM F RATE APPENDICES, METHOD FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION
KR102580320B1 (ko) * 2017-01-27 2023-09-19 신텔라 에이비 골 및 연골 손상 또는 질환의 예방 및 치료
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
JP7454379B2 (ja) 2017-12-28 2024-03-22 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
US20210047621A1 (en) 2018-03-12 2021-02-18 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
US12702683B2 (en) 2019-01-03 2026-08-11 Mesoblast International Sárl Method for improving visual acuity
WO2020251020A1 (ja) 2019-06-14 2020-12-17 株式会社カネカ 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
US11583402B2 (en) 2019-07-16 2023-02-21 William Baumgartl Method for treating joint pain
US20220348880A1 (en) * 2019-08-30 2022-11-03 The Texas A&M University System Xenogen-Free Mesenchymal Stem Cell Compositions and Methods of Use
EP4065692A4 (en) * 2019-11-26 2023-06-14 Cells For Cells S.A. MESENCHYMAL STEM CELLS WITH IMPROVED THERAPEUTIC PROPERTIES
WO2021226373A2 (en) 2020-05-08 2021-11-11 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
US12278085B2 (en) 2022-04-06 2025-04-15 Applied Materials Israel Ltd. Hybrid scanning electron microscopy and acousto-optic based metrology
WO2025076042A1 (en) * 2023-10-02 2025-04-10 MAM Holdings of West Florida, L.L.C. Mesenchymal stem cell-mediated treatments for the prevention and targeted treatment of injured tissues and promotion of tissue repair, healing, and regeneration
US12631442B2 (en) 2023-11-13 2026-05-19 Applied Materials Israel Ltd. Depth profiling of semiconductor structures using multi-wavelength pump-probe technique
CN120866212B (zh) * 2025-09-28 2026-02-24 山东省泉溪生物技术有限公司 一种用于膝关节炎治疗的羊膜间充质干细胞及其制备方法与应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US5053050A (en) * 1988-04-29 1991-10-01 Samuel Itay Compositions for repair of cartilage and bone
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
FR2667788B1 (fr) * 1990-10-12 1994-12-02 Oreal Utilisation d'hydroxyalkylamino-9,10-anthraquinones pour la teinture de fibres keratiniques humaines, composition cosmetique les contenant en association avec des colorants azouiques et nitres.
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5326357A (en) * 1992-03-18 1994-07-05 Mount Sinai Hospital Corporation Reconstituted cartridge tissue
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US5716616A (en) * 1995-03-28 1998-02-10 Thomas Jefferson University Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
CA2237890C (en) * 1995-11-16 2011-03-29 Case Western Reserve University In vitro chondrogenic induction of human mesenchymal stem cells
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
WO1997022371A1 (en) * 1995-12-18 1997-06-26 Collagen Corporation Crosslinked polymer compositions and methods for their use
US6200606B1 (en) * 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5842477A (en) * 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
AU7481098A (en) * 1997-05-13 1998-12-08 Case Western Reserve University Osteoarthritis cartilage regeneration using human mesenchymal stem ce lls
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
US6082364A (en) * 1997-12-15 2000-07-04 Musculoskeletal Development Enterprises, Llc Pluripotential bone marrow cell line and methods of using the same
DE69922933T2 (de) * 1998-03-13 2005-12-29 Osiris Therapeutics, Inc. Anwendungen für humane nicht autologe, mesenchymale stammzellen
IT1299488B1 (it) * 1998-06-01 2000-03-16 Afatec S R L Tubo corrugato bimetallico e procedimento per la sua realizzazione
BR0008787A (pt) * 1999-02-12 2001-11-06 Collagenesis Inc Sistema à base de colágeno injetável para aplicação de células ou agentes terapêuticos
US6716616B1 (en) * 1999-09-28 2004-04-06 Lexicon Genetics Incorporated Human kinase proteins and polynucleotides encoding the same
WO2001080865A2 (en) * 2000-04-25 2001-11-01 Osiris Therapeutics, Inc. Joint repair using mesenchymal stem cells

Also Published As

Publication number Publication date
JP6382262B2 (ja) 2018-08-29
WO2001080865A2 (en) 2001-11-01
EP1276486B8 (en) 2011-01-19
EP1276486B2 (en) 2014-03-05
DE60143517D1 (de) 2011-01-05
JP2004507454A (ja) 2004-03-11
US20130131804A1 (en) 2013-05-23
EP1276486A2 (en) 2003-01-22
US20120148548A1 (en) 2012-06-14
EP1276486B1 (en) 2010-11-24
AU2001257236B2 (en) 2006-03-09
JP5792686B2 (ja) 2015-10-14
CA2405345A1 (en) 2001-11-01
JP2016216487A (ja) 2016-12-22
US9814580B2 (en) 2017-11-14
US9050178B2 (en) 2015-06-09
CA2405345C (en) 2012-09-18
JP5090604B2 (ja) 2012-12-05
ES2353061T3 (es) 2011-02-25
ES2353061T5 (es) 2014-04-07
JP2015128633A (ja) 2015-07-16
US20150216904A1 (en) 2015-08-06
PT1276486E (pt) 2011-02-07
AU5723601A (en) 2001-11-07
WO2001080865A3 (en) 2002-04-11
WO2001080865A9 (en) 2002-12-27
US20020005205A1 (en) 2002-01-17
US20090041730A1 (en) 2009-02-12
JP2012210437A (ja) 2012-11-01

Similar Documents

Publication Publication Date Title
DE60143517D1 (de) Wiederherstellung der gelenken mit mesenchymalen stammzellen
ATE382681T1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
YU97902A (sh) Ciklopentanoindoli, smeše koje sadrže takva jedinjenja i metodi lečenja
DE60231395D1 (de) Dezellularisierung von gewebematrixen
LU91680I2 (fr) "rilonacept et ses dérivés pharmaceutiquement acceptables (ARCALYSR)"
ES2619332T3 (es) Fosfatasa alcalina dirigida al hueso, kits y métodos de uso de la misma
CY1107649T1 (el) Συνδυασμος ο οποιος περιεχει ενα αντιφολικο αλας και παραγοντα ελαττωσης μεθυλομηλονικου οξεος
BG108492A (bg) Използване на въглероден окис за подобряване на резултатите при трансплантация на тъкани и органи и потискане на апоптозата
ATE332288T1 (de) Keramischer schaumkörper
ES2164713T3 (es) Produccion recombinante de nuevos poliquetidos.
TR200103337T2 (tr) Protez inhibit”rleri olarak yeni bileçikler ve bileçimler
DK1301201T3 (da) Behandling af glycogenosis type II
ATE394148T1 (de) Socke
DE60115842D1 (de) Ventilanordnung
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
EP1553975A4 (en) OPTIMIZED FC VARIANTS AND MANUFACTURING METHOD THEREFOR
DE60118544D1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
SE0303461L (sv) Förfarande och arrangemang för att lägesorientera brygga eller bro till dentala implantat
ATE333896T1 (de) Vaskularisierungsinhibitoren
DE60122337D1 (de) Verwendung von taci als antitumormittel
BG103096A (en) Thrombin inhibitors
NO2019032I1 (no) Treosulfan
NO970473D0 (no) N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika
DK1272127T3 (da) Fremgangsmådet til fremstilling af ligament-erstatningskonstruktioner
DK2078531T3 (da) Farmaceutiske sammensætninger og fremgangsmåder, der kan anvendes til modulering af angiogenese

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties